Stock Quality:
Last 90 days
-96%
Trailing 12 Months
-99.4%
TRVN RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2024 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 2.1M | 2.6M | 3.1M |
| 2022 | 1.1M | 1.6M | 0 | 0 |
| 2021 | 3.3M | 3.5M | 637.0K | 567.0K |
| 2020 | 4.7M | 4.1M | 3.6M | 3.1M |
| 2019 | 0 | 0 | 0 | 5.2M |
| 2018 | 0 | 4.4M | 5.5M | 5.7M |
| 2016 | 7.5M | 7.5M | 5.6M | 3.8M |
| 2015 | 1.6M | 3.0M | 4.4M | 6.3M |
| 2013 | 339.4K | 271.3K | 203.1K | 135.0K |
| 2012 | 0 | 0 | 0 | 407.6K |
| CEO | Ms. Carrie L. Bourdow |
|---|---|
| WEBSITE | trevena.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 35 |